Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
JAMA Ophthalmology|February 4, 2021
Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility AnalysisGary C Brown, Melissa M Brown, Imtiaz Chaudhry, et al.American Journal of Ophthalmology|July 19, 2020
A Cost-Benefit Analysis of VEGF-Inhibitor Therapy for Neovascular Age-Related Macular Degeneration in the United StatesGary C Brown, Melissa M Brown, Sara B Rapuano, et al.Ophthalmology|November 3, 2007
A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degenerationMelissa M Brown, Gary C Brown, Heidi C Brown, et al.Ophthalmology and Therapy|July 10, 2023
Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular DegenerationGary C Brown, Melissa M Brown, Dennis Gierhart, et al.American Journal of Ophthalmology|October 18, 2005
The cost-utility of photodynamic therapy in eyes with neovascular macular degeneration--a value-based reappraisal with 5-year dataGary C Brown, Melissa M Brown, Joseph Campanella, et al.Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|April 26, 2022
Quality of life associated with no light perception visionGary C Brown, Melissa M Brown, Joshua D Stein, et al.Current Opinion in Ophthalmology|March 19, 2014
Financial return-on-investment of ophthalmic interventions: a new paradigmMelissa M Brown, Gary C Brown, Heidi B Lieske, et al.American Journal of Ophthalmology|February 5, 2008
The quality of life associated with presbyopiaBetsy P Luo, Gary C Brown, Solomon C Luo, et al.Current Opinion in Ophthalmology|April 11, 2012
Preference-based comparative effectiveness and cost–effectiveness: a review and relevance of value-based medicine for vitreoretinal interventionsMelissa M Brown, Gary C Brown, Heidi B Lieske, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 8, 2002
Patient, community and clinician perceptions of the quality of life associated with diabetes mellitusJennifer Landy, Joshua Stein, Melissa M Brown, et al.Pageof 11